# Fatal gene-editing trial in China raises ethics and oversight questions

_Friday, July 24, 2026 at 8:00 AM EDT · Capital · Latest · Tier 2 — Notable_

![Fatal gene-editing trial in China raises ethics and oversight questions — Primary](https://www.statnews.com/wp-content/uploads/2018/09/AdobeStock_184633987-1024x576.jpeg)

A six-year-old girl died in China after receiving an experimental brain-directed CRISPR therapy, the journal Science reported Thursday. Science wrote of the death in heart-wrenching detail, according to The Readout.

The therapy was described as experimental and directed at the brain. The report raises questions about ethics and oversight of gene-editing trials. The Readout summarized the Science article in its daily biotech newsletter.

The newsletter also noted a separate development involving an FDA panel vote on compounding pharmacies. The Readout said it will take a summer break next week and return in August.

## Sources

- [STAT](https://www.statnews.com/2026/07/24/biotech-news-fatal-gene-editing-trial-in-china-raises-ethics-questions/)

---
Canonical: https://techandbusiness.org/newswire/E9wkgiG584hMT85UD8r_6d
Retrieved: 2026-07-26T05:52:47.981Z
Publisher: Tech & Business (techandbusiness.org)